Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19
Condition: Coronavirus Infections Interventions: Drug: tixagevimab/cilgavimab 150+150 mg; Drug: tixagevimab/cilgavimab 300+300 mg; Drug: regdanvimab Sponsors: City Clinical Hospital No.52 of Moscow Healthcare Department; Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials
Molecular vs Conventional Microbiologic Diagnosis for Infections in Lung Transplantation
Conditions: Lung Transplant Infection; Molecular Diagnostic; Bacterial Infections; Pneumonia; Tracheobronchitis Intervention: Diagnostic Test: BioFire Pneumonia Panel Plus Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials